{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:05:44Z","timestamp":1792152344325,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T00:00:00Z","timestamp":1453766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T00:00:00Z","timestamp":1453766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The outcomes of patients admitted to the intensive care unit (ICU) for acute manifestation of small-vessel vasculitis are poorly reported. The aim of the present study was to determine the mortality rate and prognostic factors of patients admitted to the ICU for acute small-vessel vasculitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, multicenter study was conducted from January 2001 to December 2014 in 20 ICUs in France. Patients were identified from computerized registers of each hospital using the International Classification of Diseases, Ninth Revision (ICD-9). Inclusion criteria were (1) known or highly suspected granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis, microscopic polyangiitis (respectively, ICD-9 codes M31.3, M30.1, and M31.7), or anti\u2013glomerular basement membrane antibody disease (ICD-9 codes N08.5X-005 or M31.0+); (2) admission to the ICU for the management of an acute manifestation of vasculitis; and (3) administration of a cyclophosphamide pulse in the ICU or within 48\u00a0h before admission to the ICU. The primary endpoint was assessment of mortality rate 90\u00a0days after admission to the ICU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eighty-two patients at 20 centers were included, 94\u00a0% of whom had a recent (&lt;6\u00a0months) diagnosis of small-vessel vasculitis. Forty-four patients (54\u00a0%) had granulomatosis with polyangiitis. The main reasons for admission were respiratory failure (34\u00a0%) and pulmonary-renal syndrome (33\u00a0%). Mechanical ventilation was required in 51\u00a0% of patients, catecholamines in 31\u00a0%, and renal replacement therapy in 71\u00a0%. Overall mortality at 90\u00a0days was 18\u00a0% and\u00a0the mortality in ICU was 16 %. The main causes of death in the ICU were disease flare in 69\u00a0% and infection in 31\u00a0%. In univariable analysis, relevant factors associated with death in nonsurvivors compared with survivors were Simplified Acute Physiology Score II (median [interquartile range] 51 [38\u201382] vs. 36 [27\u201342],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005), age (67\u00a0years [62\u201374] vs. 58\u00a0years [40\u201368],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.003), Sequential Organ Failure Assessment score on the day of cyclophosphamide administration (11 [6\u201312] vs. 6 [3\u20137],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0004), and delayed administration of cyclophosphamide (5\u00a0days [3\u201314] vs. 2\u00a0days [1\u20135],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0053).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients admitted to the ICU for management of acute small-vessel vasculitis benefit from early, aggressive intensive care treatment, associated with an 18\u00a0% death rate at 90\u00a0days.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-016-1189-5","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T09:42:41Z","timestamp":1453801361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5443-2074","authenticated-orcid":false,"given":"Antoine","family":"Kimmoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Baux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Terzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Talec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Asfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Geri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Anguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Demoule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sophie","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Quenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Boisram\u00e9-Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Sonneville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ducrocq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Agrinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Pu\u00e9chal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,26]]},"reference":[{"key":"1189_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1\u201311.","journal-title":"Arthritis Rheum"},{"key":"1189_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/art.20077","volume":"51","author":"A Mahr","year":"2004","unstructured":"Mahr A, Guillevin L, Poissonnet M, Aym\u00e9 S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener\u2019s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum. 2004;51:92\u20139.","journal-title":"Arthritis Rheum"},{"issue":"5 Suppl 51","key":"1189_CR3","first-page":"S94","volume":"26","author":"R Phillip","year":"2008","unstructured":"Phillip R, Luqmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol. 2008;26(5 Suppl 51):S94\u2013104.","journal-title":"Clin Exp Rheumatol"},{"key":"1189_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/cc2937","volume":"9","author":"D Semple","year":"2005","unstructured":"Semple D, Keogh J, Forni L, Venn R. Clinical review: Vasculitis on the intensive care unit \u2013 part 2: treatment and prognosis. Crit Care. 2005;9:193\u20137.","journal-title":"Crit Care"},{"key":"1189_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MAJ.0b013e31816805fa","volume":"336","author":"F Holguin","year":"2008","unstructured":"Holguin F, Ramadan B, Gal AA, Roman J. Prognostic factors for hospital mortality and ICU admission in patients with ANCA-related pulmonary vasculitis. Am J Med Sci. 2008;336:321\u20136.","journal-title":"Am J Med Sci"},{"key":"1189_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2253-13-27","volume":"13","author":"P Befort","year":"2013","unstructured":"Befort P, Corne P, Filleron T, Jung B, Bengler C, Jonquet O, et al. Prognosis and ICU outcome of systemic vasculitis. BMC Anesthesiol. 2013;13:27.","journal-title":"BMC Anesthesiol"},{"key":"1189_CR7","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1378\/chest.06-2464","volume":"131","author":"SA Khan","year":"2007","unstructured":"Khan SA, Subla MR, Behl D, Specks U, Afessa B. Outcome of patients with small-vessel vasculitis admitted to a medical ICU. Chest. 2007;131:972\u20136.","journal-title":"Chest"},{"key":"1189_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00134-005-2563-y","volume":"31","author":"M Moreels","year":"2005","unstructured":"Moreels M, Melot C, Leeman M. Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med. 2005;31:591\u20133.","journal-title":"Intensive Care Med"},{"key":"1189_CR9","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/rheumatology\/keg322","volume":"42","author":"BA Cruz","year":"2003","unstructured":"Cruz BA, Ramanoelina J, Mahr A, Cohen P, Mouthon L, Cohen Y, et al. Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology (Oxford). 2003;42:1183\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"1189_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"L Guillevin","year":"2011","unstructured":"Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P, et al. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011;90:19\u201327.","journal-title":"Medicine (Baltimore)"},{"key":"1189_CR11","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.lpm.2013.08.003","volume":"42","author":"P Charles","year":"2013","unstructured":"Charles P, Bienvenu B, Bonnotte B, Gobert P, Godmer P, Hachulla \u00c9, et al. Rituximab: recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides. Presse Med. 2013;42:1317\u201330.","journal-title":"Presse Med"},{"key":"1189_CR12","unstructured":"Groupe Fran\u00e7ais d\u2019\u00c9tude des Vascularites (GFEV). Sch\u00e9ma d\u2019administration du cyclophosphamide pour les vascularites syst\u00e9miques [in French]. http:\/\/www.vascularites.org\/schema-d-administration\/. Accessed 20 January 2016."},{"key":"1189_CR13","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA. 1993;270:2957\u201363.","journal-title":"JAMA"},{"key":"1189_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendon\u00e7a A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. Intensive Care Med. 1996;22:707\u201310.","journal-title":"Intensive Care Med"},{"key":"1189_CR15","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68:1827\u201332.","journal-title":"Ann Rheum Dis"},{"key":"1189_CR16","first-page":"126","volume":"33","author":"S Monti","year":"2015","unstructured":"Monti S, Montecucco C, Pieropan S, Mojoli F, Braschi A, Caporali R. Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series. Clin Exp Rheumatol. 2015;33:126\u201331.","journal-title":"Clin Exp Rheumatol"},{"key":"1189_CR17","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"302","author":"JL Vincent","year":"2009","unstructured":"Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323\u20139.","journal-title":"JAMA"},{"key":"1189_CR18","first-page":"1317","volume":"24","author":"B Godeau","year":"1997","unstructured":"Godeau B, Mortier E, Roy PM, Chevret S, Bouachour G, Schlemmer B, et al. Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol. 1997;24:1317\u201323.","journal-title":"J Rheumatol"},{"key":"1189_CR19","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/art.39011","volume":"67","author":"C Pagnoux","year":"2015","unstructured":"Pagnoux C, Qu\u00e9m\u00e9neur T, Ninet J, Diot E, Kyndt X, de Wazi\u00e8res B, et al. Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy. Arthritis Rheumatol. 2015;67:1117\u201327.","journal-title":"Arthritis Rheumatol"},{"key":"1189_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010;363:211\u201320.","journal-title":"N Engl J Med"},{"key":"1189_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221\u201332.","journal-title":"N Engl J Med"},{"key":"1189_CR22","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/ndt\/gfv217","volume":"30","author":"U Specks","year":"2015","unstructured":"Specks U, Kronbichler A, Jayne DR. Pro: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab? Nephrol Dial Transplant. 2015;30:1083\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"1189_CR23","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"DR Jayne","year":"2007","unstructured":"Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18:2180\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"1189_CR24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1080\/08860220802353892","volume":"30","author":"D Frausova","year":"2008","unstructured":"Frausova D, Brejnikova M, Hruskova Z, Rihova Z, Tesar V. Outcome of thirty patients with ANCA-associated renal vasculitis admitted to the intensive care unit. Ren Fail. 2008;30:890\u20135.","journal-title":"Ren Fail"},{"key":"1189_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/03009742.2012.754939","volume":"42","author":"Z Hruskova","year":"2013","unstructured":"Hruskova Z, Casian AL, Konopasek P, Svobodova B, Frausova D, Lanska V, et al. Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study. Scand J Rheumatol. 2013;42:211\u20134.","journal-title":"Scand J Rheumatol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-016-1189-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-016-1189-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-016-1189-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-016-1189-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,9]],"date-time":"2023-04-09T03:08:26Z","timestamp":1681009706000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-016-1189-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,26]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["1189"],"URL":"https:\/\/doi.org\/10.1186\/s13054-016-1189-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,26]]},"assertion":[{"value":"2 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}